Gilgamesh Pharmaceuticals Funding & Investors
Gilgamesh is a pioneering early-stage biotech developing novel compounds that build upon the benefits of classic psychedelics with improvements of other components such as safety, tolerability, duration, and efficacy. Mental health worldwide has reached epidemic proportions and novel treatments have not kept pace with the urgent need to treat depression, anxiety, drug addiction and many other devastating diseases. Our purpose is to accelerate treatments and fundamentally improve mental health.
gilgameshpharmaceutical.comTotal Amount Raised: $82,559,840
Gilgamesh Pharmaceuticals Funding Rounds
Grant
$14,000,000
Grant Investors
National Institute on Drug Abuse (NIDA)Series B
$39,000,000
Series B Investors
Prime Movers LabGron VenturesNegev CapitalAlumni VenturesPalo SantoSatori CapitalRoute 66 VenturesJLS FundWPSS.bioSeries A
$27,000,000
Series A Investors
Prime Movers LabNoetic FundRoute 66 VenturesGron VenturesJLS FundPalo Alto InvestorsWhat If VenturesGaingelsAlumni VenturesArda KaraSeed
$125,000
Seed Investors
Y CombinatorWhat If VenturesOffline VenturesBossa Nova InvestimentosIncisive VenturesSeed
$2,434,845
Seed Investors
Rand HindiNoveus Capital
Funding info provided by Diffbot.